TRAF4 and nasopharyngeal carcinoma: To investigate the mechanism of how survivin was downregulated in TRAF4-depleted NPC cells in the presence of IR, TRAF4-depleted CNE2 and HNE3 cells were treated with MG132, a proteasome inhibitor following IR treatment.